OBJECTIVE: To examine the role of executive function in coping and behavioral outcomes in childhood acute lymphocytic leukemia (ALL) survivors. METHODS: We examined associations among several domains of executive function (working memory, behavioral inhibition, cognitive flexibility, and self-monitoring), coping, and emotional/behavioral problems in 30 children and adolescents ages 10- to 20-years old who completed treatment for ALL and 30 healthy controls matched on age and sex. RESULTS: We found partial support for our hypothesis that performance on executive function measures is associated with strategies used to cope with stress, and emotional and behavioral problems in ALL survivors. CONCLUSIONS: Findings suggest that executive function impairment may be associated with difficulties in coping and emotion regulation in a subgroup of children treated for ALL. Directions for future research on executive function deficits and coping skills in survivors of pediatric ALL are suggested.
OBJECTIVE: To examine the role of executive function in coping and behavioral outcomes in childhood acute lymphocytic leukemia (ALL) survivors. METHODS: We examined associations among several domains of executive function (working memory, behavioral inhibition, cognitive flexibility, and self-monitoring), coping, and emotional/behavioral problems in 30 children and adolescents ages 10- to 20-years old who completed treatment for ALL and 30 healthy controls matched on age and sex. RESULTS: We found partial support for our hypothesis that performance on executive function measures is associated with strategies used to cope with stress, and emotional and behavioral problems in ALL survivors. CONCLUSIONS: Findings suggest that executive function impairment may be associated with difficulties in coping and emotion regulation in a subgroup of children treated for ALL. Directions for future research on executive function deficits and coping skills in survivors of pediatric ALL are suggested.
Authors: Catherine C Peterson; Courtney E Johnson; Lisa Y Ramirez; Samantha Huestis; Ahna L H Pai; Heath A Demaree; Dennis Drotar Journal: Pediatr Blood Cancer Date: 2008-07 Impact factor: 3.167
Authors: Alexandra Harding Thomsen; Bruce E Compas; Richard B Colletti; Catherine Stanger; Margaret C Boyer; Brian S Konik Journal: J Pediatr Psychol Date: 2002 Apr-May
Authors: D P Waber; S C Carpentieri; N Klar; L B Silverman; M Schwenn; C A Hurwitz; P J Mullenix; N J Tarbell; S E Sallan Journal: J Pediatr Hematol Oncol Date: 2000 May-Jun Impact factor: 1.289
Authors: Dorie A Glover; Julianne Byrne; James L Mills; Leslie L Robison; H Stacy Nicholson; Anna Meadows; Lonnie K Zeltzer Journal: J Clin Oncol Date: 2003-12-01 Impact factor: 44.544
Authors: Brad J Zebrack; Lonnie K Zeltzer; John Whitton; Ann C Mertens; Lorrie Odom; Roger Berkow; Leslie L Robison Journal: Pediatrics Date: 2002-07 Impact factor: 9.703
Authors: Melissa M Hudson; Ann C Mertens; Yutaka Yasui; Wendy Hobbie; Hegang Chen; James G Gurney; Mark Yeazel; Christopher J Recklitis; Neyssa Marina; Leslie R Robison; Kevin C Oeffinger Journal: JAMA Date: 2003-09-24 Impact factor: 157.335
Authors: Bruce E Compas; Sarah S Jaser; Alexandra H Bettis; Kelly H Watson; Meredith A Gruhn; Jennifer P Dunbar; Ellen Williams; Jennifer C Thigpen Journal: Psychol Bull Date: 2017-06-15 Impact factor: 17.737
Authors: Amanda L Winter; Heather M Conklin; Vida L Tyc; Heather Stancel; Pamela S Hinds; Melissa M Hudson; Lisa S Kahalley Journal: J Clin Exp Neuropsychol Date: 2014-08-15 Impact factor: 2.475
Authors: Kemar V Prussien; Rachel E Siciliano; Abagail E Ciriegio; Allegra S Anderson; Radha Sathanayagam; Michael R DeBaun; Lori C Jordan; Bruce E Compas Journal: J Pediatr Psychol Date: 2020-03-01
Authors: Lindsay D Evans; Chrystyna Kouros; Sarah A Frankel; Elizabeth McCauley; Guy S Diamond; Kelly A Schloredt; Judy Garber Journal: J Abnorm Child Psychol Date: 2015-02